Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML

Clinical trial NCT05807932 · RECRUITING

Trial details

NCT number: NCT05807932
Sponsor: Heinrich-Heine University, Duesseldorf
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Secondary Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia

Start date: 2023-06-26
Primary completion: 2026-01-31
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.